ProKidney (PROK) via Social Capital Suvretta III (DNAC) deck ProKidney is a leading clinical-stage cellular therapeutics company focused on chronic kidney disease. Debarshi Ghosh 19 Jan 2022 Share on Twitter Share on Facebook Share on LinkedIn Share on Pinterest Share via Email Copy link This post is for subscribers only Subscribe Already have an account? Log in